Consolidated Statements of Shareholders' Deficit (Unaudited) - USD ($) shares in Millions, $ in Millions	Total	Common Stock	Capital in Excess of Par Value	Accumulated Deficit	Accumulated Other Comprehensive Income
Beginning balance (in shares) at Feb. 02, 2024		574
Beginning balance at Feb. 02, 2024	$ (15,050)	$ 287	$ 0	$ (15,637)	$ 300
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	5,833			5,833
Other comprehensive income (loss)	(8)				(8)
Cash dividends declared	(1,933)			(1,933)
Share-based payment expense	159		159
Repurchases of common stock (in shares)		(10)
Repurchases of common stock	(2,515)	$ (6)	(253)	(2,256)
Issuance of common stock under share-based payment plans (in shares)		1
Issuance of common stock under share-based payment plans	$ 95	$ 1	94
Ending balance (in shares) at Nov. 01, 2024	565	565
Ending balance at Nov. 01, 2024	$ (13,419)	$ 282	0	(13,993)	292
Beginning balance (in shares) at Aug. 02, 2024		568
Beginning balance at Aug. 02, 2024	(13,763)	$ 284	0	(14,342)	295
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	1,695			1,695
Other comprehensive income (loss)	(3)				(3)
Cash dividends declared	(650)			(650)
Share-based payment expense	49		49
Repurchases of common stock (in shares)		(3)
Repurchases of common stock	(758)	$ (2)	(60)	(696)
Issuance of common stock under share-based payment plans	$ 11		11
Ending balance (in shares) at Nov. 01, 2024	565	565
Ending balance at Nov. 01, 2024	$ (13,419)	$ 282	0	(13,993)	292
Beginning balance (in shares) at Jan. 31, 2025	560	560
Beginning balance at Jan. 31, 2025	$ (14,231)	$ 280	0	(14,799)	288
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	5,654			5,654
Other comprehensive income (loss)	(13)				(13)
Cash dividends declared	(1,991)			(1,991)
Share-based payment expense	171		171
Repurchases of common stock	(74)	$ (1)	(44)	(29)
Issuance of common stock under share-based payment plans (in shares)		1
Issuance of common stock under share-based payment plans	82	$ 1	81
Other	$ 20		20
Ending balance (in shares) at Oct. 31, 2025	561	561
Ending balance at Oct. 31, 2025	$ (10,382)	$ 280	228	(11,165)	275
Beginning balance (in shares) at Aug. 01, 2025		561
Beginning balance at Aug. 01, 2025	(11,400)	$ 280	147	(12,108)	281
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	1,616			1,616
Other comprehensive income (loss)	(6)				(6)
Cash dividends declared	(673)			(673)
Share-based payment expense	54		54
Repurchases of common stock	(4)		(4)
Issuance of common stock under share-based payment plans	11		11
Other	$ 20		20
Ending balance (in shares) at Oct. 31, 2025	561	561
Ending balance at Oct. 31, 2025	$ (10,382)	$ 280	$ 228	$ (11,165)	$ 275